Related Experiment Video

Updated: May 27, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart

C Zugck1, J Franke, G Gelbrich

  • 1Department of Cardiology, Angiology, Pulmonology, University of Heidelberg, Heidelberg, Germany. Christian.Zugck@med.uni-heidelberg.de

Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|December 6, 2011
PubMed

Insights

High adherence to heart failure pharmacotherapy guidelines is achievable, improving patient prognosis. However, implementation requires improvement, particularly for elderly women and those with advanced heart failure symptoms.

Area of Science:

  • Cardiology
  • Pharmacotherapy
  • Clinical Research

Background:

  • Current pharmacotherapy guidelines for heart failure aim to improve patient outcomes.
  • Assessing adherence to these guidelines is crucial for effective treatment.
  • Factors influencing adherence require identification to optimize care.

Purpose of the Study:

  • To evaluate the implementation of current heart failure pharmacotherapy guidelines.
  • To identify factors associated with high guideline adherence in heart failure patients.

Main Methods:

  • Pooled data from seven German Competence Network Heart Failure studies.
  • Analysis of 2,682 patients with chronic systolic heart failure and LVEF <45%.
  • Guideline Adherence Indicator (GAI-3 and GAI-5) used to assess pharmacotherapy quality.

Main Results:

  • 71% of patients achieved perfect adherence (GAI-3 = 100%).
  • Factors associated with perfect adherence included revascularization history, ICD implantation, and LVEF <30%.
  • Age, advanced NYHA class, unknown HF duration, and antidepressant use were negatively associated with adherence.

Conclusions:

  • High guideline adherence is achievable in clinical studies, leading to better prognosis.
  • Further improvements in heart failure medication implementation are needed for specific patient groups.
  • Optimal pharmacotherapy is linked to improved left ventricular function and reduced mortality risk.
Abstract

More Related Videos

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...